Salivary Innate Immune Peptides Correlate with Lower Dental Caries Experience in Young Adults
Background
Dental caries, a prevalent chronic disease, traditionally linked to diet and oral hygiene, involves complex host-pathogen interactions. While salivary flow rate, pH, and buffering capacity are established indicators, the role of specific innate immune components, particularly antimicrobial peptides (AMPs), in modulating caries susceptibility remains less explored. Understanding these intrinsic host defense mechanisms could reveal novel biomarkers and therapeutic targets, addressing the current gap in comprehensive caries risk assessment and personalized prevention strategies beyond conventional approaches. This study investigates the association between salivary AMP levels and caries status.
Study Design
Researchers recruited 40 healthy volunteers aged 18-35 years from university dental clinics. Participants provided stimulated saliva samples and were categorized into either a low-caries or high-caries experience group based on ICDAS criteria and DMFS index scores. Levels of specific antimicrobial peptides, including human β-defensins 1-3, histatin-5, and cathelicidin LL-37, were precisely quantified in the collected saliva using peptide-specific ELISA kits. This cross-sectional design aimed to correlate AMP concentrations with existing caries status.
Results
The study revealed a significant association between salivary antimicrobial peptide concentrations and dental caries experience.
All measured AMP concentrations—human β-defensins 1-3, histatin-5, and cathelicidin LL-37—were significantly higher in individuals classified with low caries experience compared to those with high caries experience (p < 0.001). This robust statistical difference suggests a strong protective role for these innate immune peptides. Furthermore, a clear negative association was observed between
D1-6MFS scores, a comprehensive measure of caries severity, and the concentrations of salivary AMPs. This indicates that as the levels of these protective peptides decrease, the extent of dental caries tends to increase. The consistent elevation of multiple AMPs in the low-caries group underscores their collective contribution to host defense against cariogenic challenges.
Key Findings
- Salivary human β-defensins 1-3, histatin-5, and cathelicidin LL-37 were significantly higher in individuals with low caries experience.
- All measured antimicrobial peptide concentrations were significantly higher in the low-caries group compared to the high-caries group (p < 0.001).
- A negative association was observed between D1-6MFS scores (caries severity) and salivary AMP concentrations.
- Salivary AMPs may serve as promising non-invasive biomarkers for dental caries risk assessment.
Why It Matters
Salivary antimicrobial peptides represent promising non-invasive biomarkers for enhanced dental caries risk assessment and personalized preventive strategies. This finding suggests that evaluating AMP levels could complement traditional methods, offering a more nuanced understanding of an individual's intrinsic susceptibility to caries. For clinicians, this opens avenues for identifying high-risk patients who might benefit from targeted interventions, potentially including novel peptide-based therapies or lifestyle modifications aimed at boosting innate immunity. While not a direct protocol, it highlights a critical host factor that could inform future preventive protocols, moving beyond just diet and hygiene to incorporate biological resilience.
dental-caries
antimicrobial-peptides
innate-immunity
saliva
biomarkers
human-beta-defensins